PROCTER GAMBLE HEALTH LTD Q2 RESULTS
![How Canadian dream has turned into a gamble for Indian students](https://img.etimg.com/thumb/msid-112872059,width-100,height-75,resizemode-4/nri/study/how-canadian-dream-has-turned-into-a-gamble-for-indian-students.jpg)
How Canadian dream has turned into a gamble for Indian students
Canada's pathway to permanent residency for international students and temporary foreign workers, especially from Punjab, is facing disruptions due to unemployment and economic issues. Protests have erupted as the government caps foreign worker numbers, affecting students and workers seeking permanent residency.
![Apollo Hospitals shares rise 4% after reporting 83% YoY jump in Q1 PAT. Should you buy?](https://img.etimg.com/thumb/msid-112516848,width-100,height-75,resizemode-4/markets/stocks/news/apollo-hospitals-shares-rise-4-after-reporting-83-yoy-jump-in-q1-pat-should-you-buy.jpg)
Apollo Hospitals shares rise 4% after reporting 83% YoY jump in Q1 PAT. Should you buy?
Apollo Hospitals Share Price: Apollo Hospitals' stock saw a 4.2% increase after reporting a Q1 FY25 net profit of Rs 305 crore, up from Rs 167 crore last year. Revenue grew by 15% to Rs 5,086 crore. Several brokerage firms maintained positive ratings, highlighting improvements in occupancy and revenue segments.
![Apollo 24/7 GMV to go up to Rs 1,000 cr per quarter over next 18 months: Suneeta Reddy](https://img.etimg.com/thumb/msid-112517541,width-100,height-75,resizemode-4/markets/expert-view/apollo-24/7-gmv-to-go-up-to-rs-1000-cr-per-quarter-over-next-18-months-suneeta-reddy.jpg)
Apollo 24/7 GMV to go up to Rs 1,000 cr per quarter over next 18 months: Suneeta Reddy
Apollo Hospitals' Suneeta Reddy forecasted a 5% price impact for next quarter, citing the recent muted performance from elections and a heatwave. Regional occupancy and margins varied, with Nashik serving as a referral center. Apollo 24/7 aims for Rs 1,000 crore quarterly in six quarters. AHLL is on an improving revenue trajectory despite new centers impacting margins.
![Apollo Hospitals Q1 Results: Profit zooms 83% YoY to Rs 305 crore, revenue up 15%](https://img.etimg.com/thumb/msid-112500305,width-100,height-75,resizemode-4/markets/stocks/earnings/apollo-hospitals-q1-results-profit-zooms-83-yoy-to-rs-305-crore-revenue-up-15.jpg)
Apollo Hospitals Q1 Results: Profit zooms 83% YoY to Rs 305 crore, revenue up 15%
Apollo Hospitals Q1 Results: Leading hospital chain Apollo Hospitals reported 83% growth in its consolidated net profit at Rs 305 crore for the first quarter ended June 2024. It was Rs 167 crore in the year-ago period.
![US gambling crisis feared as online betting rises](https://img.etimg.com/thumb/msid-112470749,width-100,height-75,resizemode-4/tech/technology/us-gambling-crisis-feared-as-online-betting-rises.jpg)
US gambling crisis feared as online betting rises
Legalization of sports betting in over 38 states since 2018 has resulted in rising gambling addiction, especially among young men. Revenue for states has increased, yet addiction helplines report doubling of calls. Experts emphasize the difficulty of managing the long-term social costs despite immediate financial gains.
![Metropolis Q1 results: Net profit rises 31% to Rs 38 crore](https://img.etimg.com/thumb/msid-112430513,width-100,height-75,resizemode-4/markets/stocks/earnings/metropolis-q1-results-net-profit-rises-31-to-rs-38-crore.jpg)
Metropolis Q1 results: Net profit rises 31% to Rs 38 crore
The earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBITDA margin in Q1FY25 was 25%.
- Go To Page 1
Alembic Pharma Q1 Results: Net profit rises 12% YoY to Rs 135 crore
Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 14% YoY to Rs 239 crore, while the EBITDA margins contracted 540 basis points on y-o-y basis to 15.3%
Airtel beats street view, Q1 net surges 158%
Bharti Airtel reported a significant increase in its consolidated net profit for Q1 FY25, rising more than 150% year-over-year and doubling sequentially, driven by exceptional gains, improved average revenue per user (ARPU), and reduced finance costs. The telecom giant posted a net profit of ₹4,159.9 crore, exceeding analyst estimates.
Bharti Airtel Q1 Results: Consolidated net profit doubled QoQ to Rs 4,159.9 crore
Bharti Airtel’s consolidated net profit rose 100.81% sequentially and 158% on-year to Rs 4159.9 crore, helped by a one-time gain in addition to strong broadband user additions and an increase in average revenue per user (ARPU).
Bharti Airtel Q1 Preview: Revenue may grow by 3% YoY to Rs 38,488 crore, outlook positive
Bharti Airtel is expected to report a revenue of Rs 38,488 crore for Q1 FY24, marking a 2.6% YoY increase. Net profit estimates range from Rs 2,068 crore to Rs 3,922 crore. Axis Securities has the highest revenue estimate at Rs 38,996 crore, and Prabhudas Lilladher forecasts a decline in adjusted PAT.
Mankind Pharma Q1 Results: Net profit jumps 10% to Rs 543 crore
The drug maker reported net profit of Rs 494 crore in the corresponding period of previous year.Revenue from operations rose 12.2% YoY to Rs 2,893 crore in Q1FY25. On a quarter-on-quarter (QoQ) basis revenue and net profit increased 18.5% and 14%, respectively.
Dabur Q1 Preview: Domestic volumes to drive revenue growth by 6% YoY; margins to expand
Dabur India’s revenue for Q1 2024 likely witnessed a 6% year-on-year growth, driven by rural market improvement and international business. Domestic volumes reportedly grew by 5-6%, with gross margins expected to improve by up to 200 bps YoY. Higher ad-spends were seen moderating EBITDA margins slightly.
Indus Towers Q1 Results: Net profit up 43%, to buy back shares worth Rs 2,640 cr
Indus Towers reported a 43% rise in net profit to Rs 1,926 crore for its fiscal first quarter, mainly due to tower additions from Bharti Airtel’s 5G rollout and overdue collections from Vodafone Idea. Quarterly revenue increased 4.3% to Rs 7,383 crore. The company also approved a share buyback program worth Rs 2,640 crore.
Tata Consumer shares drop over 2% as Q1 results fail to impress. Should you invest?
Tata Consumer Products reported an 8% drop in profit after tax for the first quarter ended June 2024, falling to Rs 290 crore, below estimates. Shares fell 2.3%. Revenue from operations increased 16% year-on-year to Rs 4,352 crore. The drop in profit was attributed to higher exceptional items and lower returns from joint ventures and associates.
Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crore
Piramal Pharma Q1 Earnings: Piramal Pharma narrowed its net loss to Rs 89 crore in Q1FY25 from a net loss of Rs 99 crore in the corresponding quarter of the previous year.
Cipla Q1 Results: Cons PAT rises 18% YoY to Rs 1,178 crore, beats estimates
Cipla Q1 Results: The profit beat the ET Now Poll estimates of Rs 1,071 crore. Revenue from operations in the reporting period increased 6% year-on-year to Rs 6,694 crore. EBITDA saw a 14% year-on-year increase, reaching Rs 1,716 crore. This growth was primarily driven by the One India business' branded prescription division, which experienced a 10% growth. This growth was particularly strong in focused chronic therapies like respiratory, cardiac, and urology, outpacing the market. The overall chronic mix in the portfolio also improved by 106 basis points year-on-year, reaching 61.5%.
Go Digit shares rally 8% after PAT jumps 74% in June quarter
Shares of Go Digit General Insurance rallied 8% on Friday to a day's high of Rs 362.25 on the BSE after the company reported a 74% increase in net profit for the quarter ended June 30, 2024, reaching Rs 101 crore, up from Rs 58 crore in the same period last year.
Go Digit Q1 results: PAT jumps 74% YoY to Rs 101 crore, AUM rises by 33%
The assets under management in the April-June 2024 quarter stood at Rs 17,773 crore up from Rs 13,337 crore in Q1FY24. It was a 33% year-on-year jump. On a sequential basis, the AUM grew by 12.7% compared to Rs 15,764 crore as at March 31, 2024.
L&T shares rise 2% after 12% YoY jump in PAT. Should you buy, sell or hold?
Larsen and Toubro (L&T)’s shares rose by 2% after it reported a consolidated net profit of Rs 2,786 crore for Q1 FY25. Revenue from operations saw a 15% YoY increase, driven by robust execution in projects and manufacturing. Orders grew by 8%, with strong momentum in the Middle East, per analysts insights.
Tech Mahindra Q1 Results Preview: Revenue may fall 2% YoY on seasonal impact; deal wins to be muted
According to an average estimate from four brokerages, revenue for the reporting period is expected to decline by 1.6% year-on-year. However, sequential revenue growth is projected to be between 0.3% and 0.9%. Meanwhile, the reported net profit for the April-June 2024 period is anticipated to increase by 24% year-on-year, based on the same average estimate from the brokerages.
L&T Q1 Results: Cons PAT jumps 12% YoY to Rs 2,786 cr, revenue rises 15%
L&T Q1 Results: Revenue from operations grew 15% YoY to Rs 55,120 crore, driven by strong performance in the projects and manufacturing (P&M) portfolio, supported by a substantial order book. In the first quarter, the company secured orders worth Rs 70,936 crore at the group level, showing an 8% year-on-year increase, thanks to robust ordering activity in the Middle East.
Bajaj Finserv Q1 Results: Cons PAT rises 10% YoY to Rs 2,138 crore; total income jumps 35%
In the quarter ended June 2024, Bajaj Finserv's consolidated profit after tax (PAT) rose by 10% year-on-year (YoY) to Rs 2,138 crore, while its total income increased by 35% YoY to reach Rs 31,480 crore. Excluding the large tender-driven crop and government health businesses, growth was robust at 22%. Its profit after tax increased by 39%.
Budget 2024: ITC, Tata Consumer, other FMCG shares climb up to 5% on govt's rural, employment push
The government has made a provision of Rs 2.66 lakh crore for rural development including rural infrastructure. Finance Minister Nirmala Sitharaman, in her 7th Union Budget speech, also made a provision of Rs 1.52 lakh crore for agriculture and allied sector
Go Digit Q4 Results: PAT jumps 104% YoY to Rs 53 crore; gross written premium up 19%
The net profit stood at Rs 182 crore for the full financial year as against Rs 36 crore in FY23, recording a 405% jump. The gross written premium for the full financial year stood at 9,016 crore versus Rs 7,243 crore in FY23.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Apollo Hospitals Q4 results today: What to expect
Apollo Hospitals is expected to post healthy growth in core earnings for the quarter ended March 2024 due to improved ARPOB and Healthco operations. Analysts predict a 68% year-on-year growth in net profit for the fourth quarter.
P&G Hygiene appoints Mrinalini Srinivasan as new CFO
Procter & Gamble Hygiene and Health Care Ltd named Mrinalini Srinivasan as its new Chief Financial Officer (CFO) starting June 29, 2024. With 16 years of finance experience, Srinivasan has successfully led projects across various P&G businesses in Asia, Middle East, and Africa. She aims to drive growth and consumer satisfaction in her new role. She succeeds Prashant Bhatnagar.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Load More